FARMACOLOGÍA DEL DOLOR EXPERIMENTAL
FARMADEX
Universidad Autónoma de Madrid
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Universidad Autónoma de Madrid (7)
2022
-
Microsomal prostaglandin E synthase-1 is involved in the metabolic and cardiovascular alterations associated with obesity
British Journal of Pharmacology, Vol. 179, Núm. 11, pp. 2733-2753
2020
-
Aging-Associated miR-217 Aggravates Atherosclerosis and Promotes Cardiovascular Dysfunction
Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 40, Núm. 10, pp. 2408-2424
-
Myeloid GRK2 regulates obesity-induced endothelial dysfunction by modulating inflammatory responses in perivascular adipose tissue
Antioxidants, Vol. 9, Núm. 10, pp. 1-17
2019
-
1-(2′,5′-Dihydroxyphenyl)-3-(2-fluoro-4-hydroxyphenyl)-1-propanone (RGM079): A Positive Allosteric Modulator of α7 Nicotinic Receptors with Analgesic and Neuroprotective Activity
ACS Chemical Neuroscience, Vol. 10, Núm. 8, pp. 3900-3909
2018
-
Branched-chain amino acids promote endothelial dysfunction through increased reactive oxygen species generation and inflammation
Journal of Cellular and Molecular Medicine, Vol. 22, Núm. 10, pp. 4948-4962
-
MPGES-1 (Microsomal prostaglandin E synthase-1) mediates vascular dysfunction in hypertension through oxidative stress
Hypertension, Vol. 72, Núm. 2, pp. 492-502
2016
-
Role of COX-2-derived PGE2 on vascular stiffness and function in hypertension
British Journal of Pharmacology, Vol. 173, Núm. 9, pp. 1541-1555